Liquidia Corp. (LQDA)
70.28
+1.66
(+2.41%)
USD |
NASDAQ |
Aug 24, 16:00
70.28
0.00 (0.00%)
After-Hours: 20:00
Liquidia Net Income (Quarterly) : 74.72M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.72M |
| March 31, 2026 | 52.86M |
| December 31, 2025 | 14.56M |
| September 30, 2025 | -3.533M |
| June 30, 2025 | -41.58M |
| March 31, 2025 | -38.37M |
| December 31, 2024 | -38.51M |
| September 30, 2024 | -31.03M |
| June 30, 2024 | -28.67M |
| March 31, 2024 | -30.08M |
| December 31, 2023 | -27.45M |
| September 30, 2023 | -15.79M |
| June 30, 2023 | -23.52M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -6.533M |
| September 30, 2022 | -9.092M |
| June 30, 2022 | -9.447M |
| March 31, 2022 | -15.94M |
| December 31, 2021 | -11.56M |
| Date | Value |
|---|---|
| September 30, 2021 | -7.281M |
| June 30, 2021 | -6.552M |
| March 31, 2021 | -9.183M |
| December 31, 2020 | -16.09M |
| September 30, 2020 | -14.97M |
| June 30, 2020 | -13.92M |
| March 31, 2020 | -14.79M |
| December 31, 2019 | -14.49M |
| September 30, 2019 | -13.42M |
| June 30, 2019 | -5.901M |
| March 31, 2019 | -13.77M |
| December 31, 2018 | -9.686M |
| September 30, 2018 | -9.673M |
| June 30, 2018 | -6.269M |
| March 31, 2018 | -27.51M |
| December 31, 2017 | 8.210M |
| September 30, 2017 | -19.24M |
| June 30, 2017 | -8.291M |
| March 31, 2017 | -9.837M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 122.00M |
| Harmony Biosciences Holdings, Inc. | 75.43M |
| Johnson & Johnson | 5.534B |
| Amneal Pharmaceuticals, Inc. | 69.61M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 171.68M |
| Total Expenses (Quarterly) | 96.96M |
| EPS Diluted (Quarterly) | 0.7369 |
| Enterprise Value | 6.013B |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | 43.52% |
| Earnings Yield | 1.94% |
| Operating Earnings Yield | 2.47% |
| Normalized Earnings Yield | 1.941 |